DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Vasopressinis the generic ingredient in three branded drugs marketed by Am Regent, Par Sterile Products, and Parke Davis, and is included in three NDAs. There are fourteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
There are nine drug master file entries for vasopressin. Two suppliers are listed for this compound.
Summary for vasopressin
|Drug Master File Entries:||9|
|Finished Product Suppliers / Packagers:||2|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for vasopressin|
|What excipients (inactive ingredients) are in vasopressin?||vasopressin excipients list|
|DailyMed Link:||vasopressin at DailyMed|
Recent Clinical Trials for vasopressin
Identify potential brand extensions & 505(b)(2) entrants
|La Jolla Pharmaceutical Company||Phase 4|
|University Hospital, Clermont-Ferrand||Phase 4|
|University of California, San Francisco||Phase 2/Phase 3|